Literature DB >> 22942833

Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

Bruce A Feinberg1, James Lang, James Grzegorczyk, Donna Stark, Thomas Rybarczyk, Thomas Leyden, Joseph Cooper, Thomas Ruane, Scott Milligan, Philip Stella, Jeffrey A Scott.   

Abstract

Despite rising medical costs within the US health care system, quality and outcomes are not improving. Without significant policy reform, the cost-quality imbalance will reach unsustainable proportions in the foreseeable future. The rising cost of health care in part results from an expanding aging population with an increasing number of life-threatening diseases. This is further compounded by a growing arsenal of high-cost therapies. In no medical specialty is this more apparent than in the area of oncology. Numerous attempts to reduce costs have been attempted, often with limited benefit and brief duration. Because physicians directly or indirectly control or influence the majority of medical care costs, physician behavioral changes must occur to bend the health care cost curve in a sustainable fashion. Experts within academia, health policy, and business agree that a significant paradigm change in stakeholder collaboration will be necessary to accomplish behavioral change. Such a collaboration has been pioneered by Blue Cross Blue Shield of Michigan and Physician Resource Management, a highly specialized oncology health care consulting firm with developmental and ongoing technical, analytic, and consultative support from Cardinal Health Specialty Solutions, a division of Cardinal Health. We describe a successful statewide collaboration between payers and providers to create a cancer clinical care pathways program. We show that aligned stakeholder incentives can drive high levels of provider participation and compliance in the pathways that lead to physician behavioral changes. In addition, claims-based data can be collected, analyzed, and used to create and maintain such a program.

Entities:  

Year:  2012        PMID: 22942833      PMCID: PMC3348604          DOI: 10.1200/JOP.2012.000564

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  15 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Prior-authorization programs for controlling drug spending.

Authors:  Mary Beth Hamel; Arnold M Epstein
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

3.  Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Authors:  Michael A Fischer; Sebastian Schneeweiss; Jerry Avorn; Daniel H Solomon
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

4.  Delivering affordable cancer care in high-income countries.

Authors:  Richard Sullivan; Jeffrey Peppercorn; Karol Sikora; John Zalcberg; Neal J Meropol; Eitan Amir; David Khayat; Peter Boyle; Philippe Autier; Ian F Tannock; Tito Fojo; Jim Siderov; Steve Williamson; Silvia Camporesi; J Gordon McVie; Arnie D Purushotham; Peter Naredi; Alexander Eggermont; Murray F Brennan; Michael L Steinberg; Mark De Ridder; Susan A McCloskey; Dirk Verellen; Terence Roberts; Guy Storme; Rodney J Hicks; Peter J Ell; Bradford R Hirsch; David P Carbone; Kevin A Schulman; Paul Catchpole; David Taylor; Jan Geissler; Nancy G Brinker; David Meltzer; David Kerr; Matti Aapro
Journal:  Lancet Oncol       Date:  2011-09       Impact factor: 41.316

5.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

6.  Strategic use of clinical pathways.

Authors:  Dean H Gesme; Marian Wiseman
Journal:  J Oncol Pract       Date:  2011-01       Impact factor: 3.840

7.  Cancer's next frontier: addressing high and increasing costs.

Authors:  Elena B Elkin; Peter B Bach
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

8.  Facilitators and barriers to implementing clinical care pathways.

Authors:  Sara Evans-Lacko; Manuela Jarrett; Paul McCrone; Graham Thornicroft
Journal:  BMC Health Serv Res       Date:  2010-06-28       Impact factor: 2.655

9.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

10.  Slowing the growth of health care costs--lessons from regional variation.

Authors:  Elliott S Fisher; Julie P Bynum; Jonathan S Skinner
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

View more
  8 in total

1.  A scoping review of clinical decision support tools that generate new knowledge to support decision making in real time.

Authors:  Anna Ostropolets; Linying Zhang; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2020-12-09       Impact factor: 4.497

2.  Patient preferences on the use of technology in cancer surveillance after curative surgery: A cross-sectional analysis.

Authors:  Amblessed E Onuma; Elizabeth Palmer Kelly; Jeffery Chakedis; Anghela Z Paredes; Diamantis I Tsilimigras; Brianne Wiemann; Morgan Johnson; Katiuscha Merath; Ozgur Akgul; Jordan Cloyd; Timothy M Pawlik
Journal:  Surgery       Date:  2019-02-13       Impact factor: 3.982

3.  Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.

Authors:  Courtney P Williams; Kelly M Kenzik; Andres Azuero; Grant R Williams; Maria Pisu; Karina I Halilova; Stacey A Ingram; Supriya K Yagnik; Andres Forero; Smita Bhatia; Gabrielle B Rocque
Journal:  Oncologist       Date:  2018-08-17

4.  Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy.

Authors:  Nirosha Mahendraratnam; Joel F Farley; Ethan Basch; Amber Proctor; Stephanie B Wheeler; Stacie B Dusetzina
Journal:  Support Care Cancer       Date:  2019-03-26       Impact factor: 3.603

5.  Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective Treatment.

Authors:  Nikhil G Thaker; Ankit Agarwal; Matthew Palmer; Rosemarie Hontiveros; Stephen M Hahn; Bruce D Minsky; Ronald Walters; John Bingham; Thomas W Feeley; Thomas A Buchholz; Steven J Frank
Journal:  Int J Part Ther       Date:  2016-03-24

6.  When time matters: a qualitative study on hospital staff's strategies for meeting the target times in cancer patient pathways.

Authors:  Line Melby; Erna Håland
Journal:  BMC Health Serv Res       Date:  2021-03-09       Impact factor: 2.655

7.  Value-Based Care in Lung Cancer.

Authors:  Keith D Eaton; Barbara Jagels; Renato G Martins
Journal:  Oncologist       Date:  2016-06-02

8.  Restructuring Skin Cancer Care in Ontario: A Provincial Plan.

Authors:  John Milkovich; Tim Hanna; Carolyn Nessim; Teresa M Petrella; Louis Weatherhead; An-Wen Chan; Jonathan C Irish; Christian Murray; Grace Bannerman; Claire Holloway; Katharina Forster; Laura Pazzano; Frances C Wright
Journal:  Curr Oncol       Date:  2021-03-12       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.